Literature DB >> 10357269

Enterococci at the crossroads of food safety?

C M Franz1, W H Holzapfel, M E Stiles.   

Abstract

Enterococci are gram-positive bacteria and fit within the general definition of lactic acid bacteria. Modern classification techniques resulted in the transfer of some members of the genus Streptococcus, notably some of the Lancefield's group D streptococci, to the new genus Enterococcus. Enterococci can be used as indicators of faecal contamination. They have been implicated in outbreaks of foodborne illness, and they have been ascribed a beneficial or detrimental role in foods. In processed meats, enterococci may survive heat processing and cause spoilage, though in certain cheeses the growth of enterococci contributes to ripening and development of product flavour. Some enterococci of food origin produce bacteriocins that exert anti-Listeria activity. Enterococci are used as probiotics to improve the microbial balance of the intestine, or as a treatment for gastroenteritis in humans and animals. On the other hand, enterococci have become recognised as serious nosocomial pathogens causing bacteraemia, endocarditis, urinary tract and other infections. This is in part explained by the resistance of some of these bacteria to most antibiotics that are currently in use. Resistance is acquired by gene transfer systems, such as conjugative or nonconjugative plasmids or transposons. Virulence of enterococci is not well understood but adhesins, haemolysin, hyaluronidase, aggregation substance and gelatinase are putative virulence factors. It appears that foods could be a source of vancomycin-resistant enterococci. This review addresses the issue of the health risk of foods containing enterococci.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357269     DOI: 10.1016/s0168-1605(99)00007-0

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  96 in total

1.  Probiotics in the Treatment of Diarrheal Diseases.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Bacteriological evaluation of dog and cat diets that claim to contain probiotics.

Authors:  J Scott Weese; Luis Arroyo
Journal:  Can Vet J       Date:  2003-03       Impact factor: 1.008

Review 3.  Two-component signal transduction in Enterococcus faecalis.

Authors:  Lynn Hancock; Marta Perego
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

4.  Pathogenic Mechanisms of Enterococcal Endocarditis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

5.  An Update on the Emergence of Glycopeptide Resistance in Enterococci.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

6.  Evaluation of deficiencies in labeling of commercial probiotics.

Authors:  J Scott Weese
Journal:  Can Vet J       Date:  2003-12       Impact factor: 1.008

7.  Identification with multiplex PCR assay of enterococcus species isolated from dairy products in Umbria, Italy.

Authors:  B T Cenci Goga; L Aquilanti; A Osimani; D Miraglia; F Aloisio
Journal:  Vet Res Commun       Date:  2003-09       Impact factor: 2.459

8.  Cognitive skills and bacterial load: comparative evidence of costs of cognitive proficiency in birds.

Authors:  Juan José Soler; Juan Manuel Peralta-Sánchez; Manuel Martín-Vivaldi; Antonio Manuel Martín-Platero; Einar Flensted-Jensen; Anders Pape Møller
Journal:  Naturwissenschaften       Date:  2011-12-15

9.  Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy.

Authors:  Katie L Mason; John R Erb Downward; Kelly D Mason; Nicole R Falkowski; Kathryn A Eaton; John Y Kao; Vincent B Young; Gary B Huffnagle
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

10.  Safety evaluation in vitro of Enterococcus durans from Tibetan traditional fermented yak milk.

Authors:  Jing Li; Fazheng Ren; Huiyong Gu; Xiaopeng Li; Bozhong Gan
Journal:  J Microbiol       Date:  2011-11-09       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.